After visually inspecting the inlay and reviewing the dhr, visual acuity table, and circumstantial information about the case this incident is reportable to the fda.However, it is not possible to definitively say that the incident is entirely due to the kamra inlay.The surgeon performed a secondary procedure to correct a misaligned inlay, and then problems continued to persist prompting the explant.Continuous symptoms from prior to the recentration indicate the ucva scores may be attributed to a second centration issue.
|